Trump Thanks Novartis, The Second Drug Company To Bow To His Pressure On Price Increases

Trump thanks Novartis, the second drug company to bow to his pressure on price increases

BING NEWS:
  • Pharmalittle: We’re reading about Sanders’ pharma pressure campaign, AstraZeneca’s new ADC factory, and more
    Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.
    05/20/2024 - 2:04 am | View Link
  • Bernie Sanders may have reached the limits of his pharma pressure campaign
    Bernie Sanders may have reached the limits of his campaign to pressure pharmaceutical companies into lowering their prices.
    05/19/2024 - 9:30 pm | View Link
  • Maintaining Hold on Novartis Amid Modest Growth Projections and Long-Term Caution
    TD Cowen analyst Steve Scala maintained a Hold rating on Novartis (NVS – Research Report) yesterday and set a price target of $119.00.
    05/18/2024 - 5:55 am | View Link
  • Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation
    US Senator Bernie Sanders has ramped up the pressure on Novo Nordisk after launching an investigation into GLP-1 agonist prices last month, warning in a report that the blockbuster drugs could ...
    05/17/2024 - 6:49 am | View Link
  • Novartis Meets Offer Conditions To Buy MorphoSys In EUR 68/shr Cash Deal
    Novartis Pharma AG, affiliated to Swiss drug major Novartis AG (NVS), announced Thursday that it has met all tender offer conditions ...
    05/15/2024 - 11:45 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News